-
-
Biotech leader jumps to oncology CRO Pi Health
-
Acelyrin loses interest in izokibep, lays off 3rd of staff to focus on looming fight for Tepezza’s crown
Ovid halts preclinical work, IV seizure program in wake of soticlestat’s phase 3 stumble
Evotec eyes 400 layoffs, citing ‘challenging market’
White House announces $150M in ARPA-H awards for precision cancer surgery
In The News
- Economic Storm Clouds Hovering Over Trump and Global Leaders August 25, 2019 By News Team
- UN: Possible to Eradicate Malaria, but Probably Not Soon August 24, 2019 By News Team
- Climate Change Turns Arctic Into Strategic, Economic Hotspot August 23, 2019 By News Team
Biotechnology Today
more-
Kezar drops solid tumor drug that has yet to prove worth in phase 1
Kezar Life Sciences is dropping its unpromising phase 1 solid tumor drug as the biotech…
Biotech leader jumps to oncology CRO Pi Health
Acelyrin loses interest in izokibep, lays off 3rd of staff to focus on looming fight for Tepezza’s crown
Ovid halts preclinical work, IV seizure program in wake of soticlestat’s phase 3 stumble
Rivus succeeds in obesity-related heart failure, posting phase 2 win for muscle-sparing molecule
Markets
more-
Weekly Market Review – November 16, 2024
Stock Markets After the exuberant post-election rally, the stock market takes a breather as winning…
Bio Space
moreEvotec eyes 400 layoffs, citing ‘challenging market’
Evotec has set its sights on scrapping around 400 roles…
White House announces $150M in ARPA-H awards for precision cancer surgery
As part of its national cancer moonshot efforts, the Biden…
To pay down debt, Baxter sells its $4.5B Vantive kidney care division to the Carlyle Group for $3.8B
The Carlyle Group is finally closing in on its major…
Global News
moreSpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
- Kezar drops solid tumor drug that has yet to prove worth in phase 1
- Biotech leader jumps to oncology CRO Pi Health
- Acelyrin loses interest in izokibep, lays off 3rd of staff to focus on looming fight for Tepezza’s crown
- Ovid halts preclinical work, IV seizure program in wake of soticlestat’s phase 3 stumble
- Evotec eyes 400 layoffs, citing ‘challenging market’
- White House announces $150M in ARPA-H awards for precision cancer surgery
- To pay down debt, Baxter sells its $4.5B Vantive kidney care division to the Carlyle Group for $3.8B
- Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs
- Rivus succeeds in obesity-related heart failure, posting phase 2 win for muscle-sparing molecule
- AI antibody generator Absci inks cancer collaboration with Memorial Sloan Kettering